Tag: Dme

In July 2014, the U.S. Food and Drug Administration (FDA) first approved EYLEA (aflibercept) for the treatment of diabetic macular edema (DME). This pivotal approval, based on robust clinical trial data, established EYLEA as a standard of care for a significant complication of diabetic eye disease.

According to reports, the sale of crutches and other mobility aids has seen steady growth, making them a common sight in retail stores. The answer to "Can a pharmacy provide crutches?" is yes, with many major and independent pharmacies offering them as a convenient, over-the-counter option.

The cost of Eylea (aflibercept) injection can pose a significant financial burden for many patients, potentially costing thousands of dollars per dose. Fortunately, financial assistance is available through various programs. This guide will walk you through **how to get Eylea for free** or with considerable financial support by leveraging manufacturer and charitable aid initiatives.

According to its manufacturer, Vabysmo is a prescription medicine given by injection into the eye to treat certain retinal diseases. When considering treatment, patients often have questions about the medication's composition, specifically, what is the generic name for Vabysmo? The answer is faricimab-svoa, a distinctive type of medication known as a biologic.